2018 ISPD Conference has ended

Create Your Own Event

2018 ISPD Conference

This program is subject to change. Speakers are added as confirmations are received.
Please note that preconference courses require separate registration.
Downloads: Oral Abstracts Poster Abstracts

08:25 CEST

Opening Ceremony and Welcome Address Queen Elisabeth Hall

08:30 CEST

Plenary Presentation by Glenn Cohen: Law and Ethics at the Cutting Edge of Reproductive Medicine Queen Elisabeth Hall

09:00 CEST

Top Abstract: T-1 Which fetuses benefit most from exome sequencing? Results from the Prenatal Assessment of Genomes and Exomes (PAGE) study Queen Elisabeth Hall

09:15 CEST

Top Abstract: T-2 The impact of additional anomalies on head growth in fetuses with congenital heart defects Queen Elisabeth Hall

09:30 CEST

Top Abstract: T-3 Evaluating individual laboratory performance for cffDNA NIPT for aneuploidies: report of the first international external quality assessment Queen Elisabeth Hall

09:45 CEST

Top Abstract: T-4 Simultaneous detection of fetal chromosome aneuploidy and monogenic diseases by a novel noninvasive prenatal testing method: Targeted And Genome-wide simultaneous sequencing (TAGs-seq) Queen Elisabeth Hall

10:00 CEST

Plenary Presentation by Kypros Nicolaides: Past and future of prenatal diagnosis Queen Elisabeth Hall

11:00 CEST

Oral Poster Presentations: Genetics Queen Elisabeth Hall

14:00 CEST

Session 2 | The Downstream Impact of Genetic Testing on Obstetric Practice Invited Presentation: Impact of PGS Queen Elisabeth Hall

14:25 CEST

Session 2 | The Downstream Impact of Genetic Testing on Obstetric Practice Invited Presentation: Impact of NIPT Queen Elisabeth Hall

14:50 CEST

Session 2 | The Downstream Impact of Genetic Testing on Obstetric Practice: Replacing mosaic embryos after PGT Queen Elisabeth Hall

15:15 CEST

Session 2 | The Downstream Impact of Genetic Testing on Obstetric Practice: 2-2 Fetal fraction (FF) characterization by zygosity in twin gestation using single nucleotide polymorphism (SNP)- based noninvasive prenatal... Queen Elisabeth Hall

15:30 CEST

Session 2 | The Downstream Impact of Genetic Testing on Obstetric Practice: 2-3 Implementing NIPT as part of a national prenatal screening program: The Dutch TRIDENT studies Queen Elisabeth Hall

15:45 CEST

Session 2 | The Downstream Impact of Genetic Testing on Obstetric Practice: 2-4 A single workflow for concurrent PGT-M, PGT-SR and PGT-A on blastomere and trophectoderm biopsies Queen Elisabeth Hall

16:30 CEST

Debate 1 - MRI should be performed on all fetuses with mild ventriculomegaly Queen Elisabeth Hall

08:30 CEST

Debate 2 - NIPT results suggesting maternal cancer should always be disclosed Queen Elisabeth Hall

09:30 CEST

Malcolm Ferguson-Smith Award: Germline mosaicism is a pitfall in PGD for X‐linked disorders. Single sperm typing detects very low frequency paternal gonadal mosaicism in a case of recurrent chondrodysplasia punctata... Queen Elisabeth Hall

09:45 CEST

Prenatal Diagnosis Journal Report Queen Elisabeth Hall

10:30 CEST

Session 4 | The expanding scope of Non-invasive prenatal testing Invited Presentation: Alternative approaches towards NIPT: Cervical cells Queen Elisabeth Hall

10:55 CEST

Session 4 | The expanding scope of Non-invasive prenatal testing Invited Presentation: Pushing the envelope in NIPT of single gene diseases through haplotyping Queen Elisabeth Hall

11:20 CEST

Session 4 | The expanding scope of Non-invasive prenatal testing Invited Presentation: 4-1 Pan-ethnic expanded carrier testing for branched chain amino acid disorders Queen Elisabeth Hall

11:34 CEST

Session 4 | The expanding scope of Non-invasive prenatal testing Invited Presentation: 4-2 Haplotyping and copy number profiling of single cells by using extended family members: broadening the applicability of... Queen Elisabeth Hall

11:48 CEST

Session 4 | The expanding scope of Non-invasive prenatal testing Invited Presentation: 4-3 Restricting NIPT for fetal fraction only, does it still make sense? Queen Elisabeth Hall

14:00 CEST

Best Early Career Investigator Finalist: E-1 The BElgian PREnatal MicroArray consortium: towards relating prenatally detected CNVs, prenatal phenotype and postnatal clinical data Queen Elisabeth Hall

14:15 CEST

Best Early Career Investigator Finalist: E-2 Improving uptake of perinatal autopsy: Lessons learned from parents and key stakeholders Queen Elisabeth Hall

14:30 CEST

Best Early Career Investigator Finalist: E-3 Sensitivity of non-invasive prenatal testing for cancer detection and treatment monitoring in pregnant women Queen Elisabeth Hall

14:44 CEST

Joe Leigh Simpson Award for Best Early Career Investigator Queen Elisabeth Hall

14:45 CEST

Plenary - Do You Agree with the Experts? Queen Elisabeth Hall

16:00 CEST

Plenary - Big data and A.I. Queen Elisabeth Hall

16:30 CEST

Late-breaking Abstract: LB-1 The potential diagnostic yield of Whole Exome Sequencing in 391 pregnancies complicated by fetal ultrasound anomalies and with normal chromosomal microarray results Queen Elisabeth Hall

16:45 CEST

Late-breaking Abstract: LB-2 A new era in aneuploidy screening for multifetal gestations: Clinical laboratory experience screening >30,000 cell-free DNA samples Queen Elisabeth Hall

17:00 CEST

ISPD General Business Meeting Queen Elisabeth Hall

08:30 CEST

Debate 3 - Gene Editing should replace embryo selection following PGD Queen Elisabeth Hall

09:30 CEST

Plenary - ISPD Pioneer in Prenatal Diagnosis and Therapy Award Queen Elisabeth Hall

10:45 CEST

Session 6 | Implementation of Exome/Genome Sequencing Into Prenatal Care Invited Presentation: Exome/genome sequencing Queen Elisabeth Hall

11:15 CEST

Session 6 | Implementation of Exome/Genome Sequencing Into Prenatal Care Invited Presentation: Value/modes of data-sharing Queen Elisabeth Hall

11:45 CEST

Session 6 | Implementation of Exome/Genome Sequencing Into Prenatal Care: 6-1 Clinical application of targeted next-generation sequencing on fetuses with congenital heart defects Queen Elisabeth Hall

12:00 CEST

Session 6 | Implementation of Exome/Genome Sequencing Into Prenatal Care: 6-2 Implementing fast whole exome sequencing (WES) as diagnostic test for fetal multiple congenital anomalies on ultrasound Queen Elisabeth Hall

12:15 CEST

Session 6 | Implementation of Exome/Genome Sequencing Into Prenatal Care: 6-3 The ethics of clinical applications of germline genome modification: A systematic review of reasons Queen Elisabeth Hall

12:30 CEST

Session 6 | Implementation of Exome/Genome Sequencing Into Prenatal Care: 6-4 Prenatal diagnosis for single gene disorders in Victoria, Australia, 1977-2015 Queen Elisabeth Hall

14:00 CEST

Closing Plenary Presentation: Intellectual disabilities and understanding genetic risk Queen Elisabeth Hall

14:45 CEST

Closing Plenary Presentation: Bioengineering and stem cell therapy Queen Elisabeth Hall

15:30 CEST

Closing Remarks Queen Elisabeth Hall